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Abstract
Wolf-Hirschhorn syndrome (WHS) is a well known genetic condition caused by a partial deletion of the short arm
of chromosome 4. The great variability in the extent of the 4p deletion and the possible contribution of additional
genetic rearrangements lead to a wide spectrum of clinical manifestations. The majority of the reports of prenatally
diagnosed WHS cases are associated with large 4p deletions identified by conventional chromosome analysis;
however, the widespread clinical use of novel molecular techniques such as array comparative genomic
hybridization (a-CGH) has increased the detection rate of submicroscopic chromosomal aberrations associated with
WHS phenotype. We provide a report of two fetuses with WHS presenting with intrauterine growth restriction as
an isolated finding or combined with oligohydramnios and abnormal Doppler waveform in umbilical artery and
uterine arteries. Standard karyotyping demonstrated a deletion on chromosome 4 in both cases [del(4)(p15.33) and
del(4)(p15.31), respectively] and further application of a-CGH confirmed the diagnosis and offered a precise
characterization of the genetic defect. A detailed review of the currently available literature on the prenatal
diagnostic approach of WHS in terms of fetal sonographic assessment and molecular cytogenetic investigation is
also provided.
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Background
Wolf-Hirschhorn syndrome (WHS; OMIM 194190) [1],
also known as deletion 4p and 4p-syndrome, is a well
known clinical condition caused by a partial deletion of
the short arm of chromosome 4. WHS was first (and
independently) described by Wolf et al. (1965) and
Hirschhorn et al. (1965) [2,3]; thereafter, more than 180
documented cases have been published in the literature,
most of them diagnosed postnatally. The prevalence of
WHS is reported to be around 1/50.000 live births with
a 2:1 female/male ratio; however, this is likely
underestimated because of under-recognition or mis-
diagnosis of affected individuals [4,5].
In the majority of cases, WHS is caused by a “pure”
deletion of 4p16 with no other cytogenetic abnormality
while in the remaining cases, there could be a more
complicated cytogenetic finding such as chromosome 4
ring, 4p- mosaicism, or a derivative chromosome 4
resulting from either a de novo or inherited unbalanced
translocation [5,6]. The complexity of the WHS-asso-
ciated basic genomic changes is an important factor
explaining phenotypic variability; though the typical
clinical features include growth restriction of prenatal
onset, profound psychomotor retardation, seizures, ske-
letal abnormalities, and a distinctive facial appearance
[7]. Associated major malformations with variable
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defects such as midline scalp defects, agenesis of corpus
callosum, cleft lip/palate, heart defects, and urinary tract
malformations [7,8].
Most prenatally diagnosed cases of WHS are asso-
ciated with large 4p deletions identified by conventional
chromosome analysis while the widespread clinical use
of novel high-resolution molecular techniques such as
array comparative genomic hybridization (a-CGH)
increased the detection rate of submicroscopic chromo-
somal aberrations that could also lead to a WHS pheno-
type. Herein, we present two WHS cases suspected
upon abnormal signs in prenatal ultrasonography, diag-
nosed with conventional cytogenetics and further char-
acterized through a-CGH. A detailed review of the
current literature on prenatal diagnosis of WHS is also
provided.
Cases presentation
Case 1
A 25-year-old primigravida was referred to our clinic at
23 weeks of gestation due to fetal intrauterine growth
restriction (IUGR). The family history was unremarkable
and first-trimester screening test for chromosomal aneu-
ploidies was normal. Ultrasound examination showed
fetal measurements (BPD, HC, AC, FL) below the 5
th
centile, consistent with severe symmetrical IUGR. Umbi-
lical artery Doppler flow velocimetry exhibited reverse
end-diastolic flow and pulsatility index (PI) was 1.83
(>95
th centile); in addition, uterine artery PI were bilat-
erally increased (>95
th centile) measuring 2.25 and 1.78
respectively and notches were present as well. No fetal
malformation was present. As the amniotic fluid volume
was reduced (AFI < 5), the ultrasound imaging of fetal
facial anomalies was hampered. Upon abnormal ultra-
sound findings, an amniocentesis was performed and
karyotype analysis led to the diagnosis of WHS which
was further confirmed by a-CGH and FISH. After
genetic counseling, termination of pregnancy was per-
formed at parents’ request at 25 weeks of gestation. A
male neonate was delivered vaginally after medical
induction with prostaglandins. Detailed pathological
examination of the proband was denied by the parents.
Case 2
A 37-year-old primigravida was referred to our clinic for
genetic counseling at 23 weeks of gestation due to pre-
sence of growth restriction in serial obstetric scans since
the 13
th week of gestation. The couple was healthy, no
consanguineous, with unremarkable medical history. An
amniocentesis was performed at 23 weeks of pregnancy,
and the fetal karyotype was compatible with the diagno-
sis of WHS. a-CGH analysis showed with high precision
a 19.3 Mb terminal 4p deletion, in the area 4p15.3-pter.
After extensive counseling, the family decided to termi-
nate the pregnancy and agreed to an autopsy for the
fetus. A female fetus was delivered at 24 weeks after
medical induction. Fetal autopsy showed external fea-
tures of facial dysmorphism with bilateral cleft lip,
hypertelorism, broad and high nasal bridge, small filter
and large ears (Figure 1). The skull was oval shaped,
consistent with the helmet-like typical description of
WHS related facial appearance. The somatometric para-
meters indicated a symmetric restriction of fetal growth.
Organ dissection showed a small cerebellum with neu-
roglial heterotopias, a cardiac defect (patent foramen
ovale), intestinal malrotation, hypoplastic kidneys, acces-
sory spleen and enlarged ovaries. Placenta was hypo-
trophic with a weight of 170 g without any significant
macroscopic or histological abnormalities; the umbilical
cord presented three vessels. Growth velocities were
equivalent to 20 weeks of pregnancy.
Cytogenetic and molecular cytogenetics analysis
Amniotic fluid was collected from case 1 and case 2 at
23 weeks of gestation. Cytogenetic analysis was per-
formed on cultured amniocytes by G-banding according
to standard procedures. At least 20 metaphases were
analyzed per case, revealing a male karyotype with term-
inal deletion of the short arm of one of chromosome 4
[46, XY, del(4)(p15.33)] in case 1, and a female karyo-
type with terminal deletion of the short arm of one of
chromosome 4 [46, XY, del(4)(p15.31)] in case 2. a-
CGH was done on DNA from cultured amniocytes to
characterize the extent of the deletions using a 100 kb
resolution array (kit 44 K) in case 1 and a 40 kb resolu-
tion (kit 180 K) in case 2. Molecular karyotyping was
carried out through oligonucleotide array-CGH plat-
forms (Agilent Technologies, Santa Clara, CA) as
described elsewhere [9].
Figure 1 Autopsy of a 24 weeks’ gestation female fetus after
pregnancy termination (Case 2) that showed external features
of facial dysmorphism with bilateral cleft lip, hypertelorism,
broad and high nasal bridge, small filter and large ears.
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from p15.33 to pter (first probe on the 44 K array at
62,447 bp, deleted), having its proximal breakpoint
between 14,678,744 bp and 14,744,566 bp (Figure 2a). In
case 2 the 19.3 deletion involved the cytobands from
p15.31 to 4pter (first probe on the 180 K array at 35,882
bp, deleted) having its proximal breakpoint between
19,341,751 bp and 19,364,876 bp (Figure 2b). The posi-
tions of oligomers refer to the Human Genome March
2006 (versions NCBI 36, hg18) assembly.
Cultured amniocytes were subjected to fluorescent in
situ hybridization (FISH) for further confirmation of the
Figure 2 a. a-CGH profile of chromosome 4 showing an terminal deletion. To the left, the whole chromosome 4 view. To the right, the
enlarged view of the rearrangement as provided by Agilent Technologies, CGH Analytics 3.5.14. The overall size of the deletion was about 14.7
Mb. b. a-CGH profile of chromosome 4 showing a terminal deletion. To the left, the whole chromosome 4 view. To the right, the enlarged view
of the rearrangement as provided by Agilent Technologies, CGH Analytics 3.5.14. The overall size of the deletion was about 19.3 Mb.
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using the commercially available TelVysion 4p Spectrum
Green probe following the manufacturer’s instructions
(Vysis Inc, Downers Grove, Ill, USA). In both cases the
probe showed a signal on only one homologue. Parental
karyotyping was found to be normal. Hybridization with
the probe on metaphase chromosomes of the parents
showed normal signal on both chromosomes 4 and
neither parent was found to carry a translocation of the
4pter region (data not shown).
Discussion
We report two cases of WHS presented with IUGR as
an isolated finding or combined with fetal and uterine
arteries Doppler abnormalities and oligohydramnios.
After invasive testing, conventional cytogenetic investi-
gation led to a diagnosis of WHS; in addition, molecular
analysis of the cultured amniocytes with a-CGH and
FISH further defined the precise breakpoints of the two
deletions.
WHS is a well-described multiple congenital anomaly
and mental retardation syndrome caused by partial dele-
tion of the short arm of chromosome 4 involving at
least a 165 kb segment of 4p16.3 [7,10,11]. Prenatal
diagnosis of WHS is usually confirmed by detection of a
cytogenetically visible 4p- deletion discovered after inva-
sive testing performed because of advanced maternal
age, severe IUGR (which is the most frequent ultra-
sound finding, associated or not with other fetal
abnormalities), or known parental balanced chromoso-
mal rearrangement [12-19]. In case 1, IUGR was further
complicated by Doppler abnormalities in the umbilical
artery, bilaterally increased uterine artery PI and oligo-
hydramnios, whereas in case 2, early onset growth
restriction was not accompanied with abnormal Doppler
or decreased amniotic fluid volume. The ultrasono-
graphic presentation of WHS with IUGR and a notch
on the uterine artery also overlap with previously
described case by Levaillant et al. [15], while oligohy-
dramnios as a unique finding or associated with other
fetal malformations has also been reported in fetuses
with WHS [20-24]. A wide range of other anatomical
abnormalitites as renal hypoplasia, skeletal dysplasias,
hypospadias, diaphragmatic hernia, single umbilical
artery also complicates these cases with variable inci-
dence [7,25-31]. In addition, craniofacial dysmorphic
features such as microcephaly, “Greek warrior helmet”
profile (the broad high nasal bridge continuing to the
forehead), prominent glabella, high arched eyebrows and
hypertelorism are strongly evocative of WHS
[7,26,32,33].
Unfortunately, minor anatomical defects indicative of
facial dysmorphism in our case 2 were missed by serial
ultrasound scans between 13 and 22 weeks. Several
reports of concomitant WHS and other structural chro-
mosomal aberrations as a result of an unbalanced trans-
location display complex phenotypes and confuse some
of the correlations [33-35]. A brief overview of the ultra-
sound features, the mode of the cytogenetic analysis
applied and the perinatal outcome in 36 WHS cases,
including our 2 cases and 34 other published cases, is
presented in Additional file 1: Table S1. In the context
of growth retardation, a reference ultrasonography with
2-D and 3-D fetal facial imaging and/or a detailed pre-
natal fetal brain evaluation with CT/MRI analysis and
fetal echocardiography could be helpful in adding clues
towards diagnosis and orientate karyotype analysis on
4p- extremities [15,36,37].
Regarding the molecular basis of WHS, in about 55%
of cases, WHS results from an isolated 4p deletion (a
so-called “’pure deletion”); about 40-45% of affected
individuals have an unbalanced translocation (de novo
or inherited from a familial balanced rearrangement)
characterized by both a deletion of 4p and a partial tris-
omy of a different chromosome arm; in the remaining
cases, there is a complex rearrangement leading to a
4p16.3 deletion (e.g., chromosome 4 ring) [38,39]. Unba-
lanced translocations involving the short arms of chro-
mosomes 4 and 8 appear with high frequency in several
large series of WHS patients [40-43]. These rearrange-
ments usually arise as a result of a) a homologous non-
allelic recombination mediated by olfactory receptors
( O R ) - g e n ec l u s t e r si nb o t h4 pa n d8 p ,o rb )ap a r e n t a l
inversion polymorphism on 4p16 [44,45]. Recent studies
point to a multigenic profile of WHS that contributes to
the complex phenotype though two critical regions
(WHSCR1 and -2) have been implicated in the patho-
genesis of the syndrome [8,46,47]. WHSCR-1 is a 165
kb area approximately 2 Mb from the telomere of 4p
and includes the WHS candidate gene 2 (WHSC2)a n d
part of WSHC1 which is implicated in growth delay and
facial characteristics [48-50]. WHSCR-2, that contributes
to the basic phenotype (typical craniofacial pattern, mild
mental retardation, growth delay and seizures) resides in
a 300-600 kb interval positioned between 1.9 and 1.6-1.3
Mb from the telomere and is contiguous and telomeric
to WHSCR-1. This genomic region includes a third criti-
cal gene called LETM1 (leucine zipper/EF-hand-contain-
ing transmembrane) associated with the neuromuscular
features of WHS patients such as seizures disorders
[5,51], and partially the WHSC1. Moreover, recent stu-
dies suggest that the fibroblast growth factor receptor-
like 1 (FGFRL1) represents a plausible candidate gene
for part of the craniofacial phenotype of WHS [47,52].
An increasing number of genotype-phenotype correla-
tion studies compare specific clinical features of patients
with different sized 4p deletions in order to refine the
4p phenotypic map but the variable expressivity or
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WHS is likely to be a contiguous gene syndrome, makes
it a challenging task. According to a recent study WHS
cases can be divided into three clinical categories: the
first one comprises a microdeletion not exceeding 3.5
Mb at 4p16-4pter results in a mild phenotype and is
likely to be under diagnosed, the second one is asso-
ciated to deletions between 5 and 18 Mb that present
with severe psychomotor delay and typical abnormalities
whereas those greater than 22 Mb at 4p15-4pter consist
the third category associated with major malformations
[8]. However, Battaglia et al. (2001) demonstrated that a
submicroscopic deletion that was detected only by FISH
may account for the severe WHS phenotype and con-
cluded that there is no such a strict correlation [53].
Alternative mechanisms that can lead to complex phe-
notypes include: a) unbalanced translocation mutations
resulting in 4p deletion and partial trisomy affecting the
final phenotype; b) allelic variation in the homologous
4p region; c) mutations in modifier genes located out-
side the deleted regions; d) position effects and telomere
silencing; e) different genetic background and post-zygo-
tic mutational events [43,46]. Differential diagnosis of
WHS should include the proximal interstitial 4p dele-
tion which is a discrete syndrome that usually involves
bands 4p12-p16 that are proximal to and exclude the
WHS critical region [54].
The majority of prenatally diagnosed cases of WHS
reported in the medical literature are delineated by con-
ventional cytogenetic analysis, but during the last decade
the availability of new technologies especially a-CGH have
enabled a more precise description of the molecular
mechanisms that can account for the WHS phenotype
[23,55]. Indeed, few published reports refer to cases that a
standard karyotype was interpreted as normal and a
required subsequent molecular analysis by FISH or/and a-
CGH upon prenatally or postnatally identified fetal mal-
formations allowed the final diagnosis [11,33,37,56]. A pre-
natal misdiagnosis of a WHS case is more likely when the
fetus presents only with fetal growth restriction or other
non-specific or minor features and the standard karyotype
results to be balanced [15,23,36,37,57]. Conventional G-
banded cytogenetic analysis seems to detect approximately
50-60% of WHS cases while application of FISH analysis
using a WHSCR probe detects more that 95% of deletions
in WHS [39,53]. In addition, a-CGH can detect all cur-
rently known deletions of the WHSCR and determine if
the deletion is “pure” or part of a more complex imbalance
more accurately than either FISH or conventional G-band
analysis alone [39]. A comprehensive analysis of the role
of a-CGH in the evaluation of WHS patients demon-
strated that the true prevalence of unbalanced transloca-
tions is certainly higher than reported previously and is
approximately 45% as both karyotype and routine FISH
analysis of the region may not detect these cases; also a-
CGH adds information on approximate size of both the
deletion and duplication compared to a subtelomeric
FISH assay [43]. Although both of our cases were asso-
ciated with cytogenetically visible deletions, we applied a-
CGH analysis to confirm that they were pure distal dele-
tions, to define their extent at molecular level and to
establish a firm diagnosis. We also applied FISH analysis
to further confirm our findings, to extend the investigation
to both couples and define the potential presence of a
balanced rearrangement involving 4p16.3 in the parents of
a proband so as to provide a thorough genetic counseling.
In conclusion, growth restriction as an isolated finding or
associated with facial dysmorphism and/or other major
malformations such as renal or skeletal abnormalities and
midline fusion defects may be indicative of a WHS case
and should trigger cytogenetic investigation. A combined
diagnostic approach based on conventional karyotyping
and molecular analysis, would offer a definitive result
within the time frame required for management of the
affected pregnancy and for a prompt genetic counseling
about the long term complications and poor prognosis of
these cases. This is crucial as, according to the data pre-
sented in the Additional file 1: Table S1, most of the par-
ents opt for pregnancy termination. Furthermore, as part
of the genetic counseling prenatal testing should be
offered to families in which one parent is known to be a
carrier of a chromosome rearrangement involving 4p16.3
Additional investigation with high-resolution techniques
such as a-CGH is nowadays strongly recommended parti-
cularly in case of discordance between prenatal ultrasound
findings and normal karyotype. In the future, the imple-
mentation of this technique in the routine practice of pre-
natal diagnosis will improve the diagnostic yield in
pregnancies with abnormal ultrasound findings and parti-
cularly to WHS, it will enable a more precise estimation of
the true incidence of the syndrome and will advance our
knowledge regarding the genotype-phenotype correlations.
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